PAR 3.45% 28.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-160

  1. 113 Posts.
    lightbulb Created with Sketch. 19
    Farmerbob was correct it was a positive announcement. What the market does is beyond his insight.....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.